Relay Therapeutics, Inc.
Nasdaq: RLAYBiological Products, (No Diagnostic Substances) · Entity-resolved by Clous
CIK0001812364
TickerRLAY
ExchangeNasdaq
SIC2836
StateDE
FY end12-31
Illustrative profile — live data lights up when a server API key is configured.
Key financials
RevenueFY2025-12-31
$15.36M
+53.4% YoY
Net IncomeFY2025-12-31
-$276.48M
+18.1% YoY
Total AssetsFY2025-12-31
$621.33M
-28.7% YoY
EquityFY2025-12-31
$567.06M
-27.1% YoY
Shares OutstandingFY2025-12-31
178.73M
—
Operating Cash FlowFY2025-12-31
-$235.46M
+5.5% YoY
Market
Market
RLAYClose price
$15.88
Market cap
$3.04B
delayed EOD · as of 2026-06-18
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | $1.38M | $25.55M | $10.01M | $15.36M | +53.4% | 100% |
| Net Income | -$290.51M | -$341.97M | -$337.71M | -$276.48M | +18.1% | -1801% |
| Total Assets | $1.1B | $843.98M | $871.3M | $621.33M | -28.7% | 4046% |
| Equity | $950.22M | $752M | $777.79M | $567.06M | -27.1% | 3693% |
| Operating Cash Flow | -$229.49M | -$300.32M | -$249.11M | -$235.46M | +5.5% | -1533% |
| Shares Outstanding | — | — | — | 178.73M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001812364